, Tracking Stock Market Picks
Enter Symbol:
Stereotaxis, Inc. (STXS) [hlAlert]

down 97.16 %

Stereotaxis, Inc. (STXS) rated Outperform with price target $10 by Barrington Research

Posted on: Tuesday,  Mar 25, 2008  8:25 AM ET by Barrington Research

Barrington Research rated Outperform Stereotaxis, Inc. (NASDAQ: STXS) on 03/25/2008, when the stock price was $55.40. Since
then, Stereotaxis, Inc. has lost 97.17% as of 01/21/2016's recent price of $1.57.
If you would have followed this Barrington Research's recommendation on STXS, you would have lost 97.16% of your investment in 2858 days.

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to allow physicians to navigate catheters, guidewires and stent delivery devices through the blood vessels and chambers of the heart to treatment sites.

As our name implies, research plays a central role in everything we do. Whether we're dealing with sales, trading, investment banking or asset management, insightful research is indispensable in providing value to our clients. Our research provides us with a comprehensive understanding of the economy, financial markets, and individual companies, all of which are essential in recommending successful investments.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/25/2008 8:25 AM Buy
55.40 100.00
as of 12/24/2008
1 Week down  -2.34 %
1 Month down  -14.17 %
3 Months up  29.57 %
1 YTD down  -24.31 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy